Activity of orotomide F901318 against clinical isolates of Scedosporium spp. and Lomentospora prolificans

被引：0
|
作者：
Alastruey Izquierdo, A. [1 ]
Rivero-Menendez, O. [1 ]
机构：
[1] ISCIII, Natl Ctr Microbiol, Majadahonda, Spain
来源：
MYCOSES | 2017年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P317
引用
收藏
页码：211 / 211
页数：1
相关论文
共 50 条
  • [21] In vitro activity of F901318 against filamentous fungi from cystic fibrosis patients
    Seufert, R.
    Dittmer, S.
    Heep, M.
    Rath, P. M.
    Steinmann, J.
    MYCOSES, 2018, 61 : 14 - 15
  • [22] In vitro activity of F901318 against filamentous fungi from cystic fibrosis patients
    Steinmann, J.
    Dittmer, S.
    Heep, M.
    Rath, P-M.
    MEDICAL MYCOLOGY, 2018, 56 : S83 - S83
  • [23] Clinical significance and antifungal susceptibility profile of 103 clinical isolates of Scedosporium species complex and Lomentospora prolificans obtained from NIH patients
    Czech, Mary M.
    Cuellar-Rodriguez, Jennifer
    Kwon-Chung, Kyung J.
    Stock, Frida
    Aneke, Chioma I.
    Olivier, Kenneth N.
    Fennelly, Kevin P.
    Gea-Banacloche, Juan
    Zerbe, Christa S.
    Freeman, Alexandra F.
    Holland, Steven M.
    Lionakis, Michail S.
    Seyedmousavi, Amir
    JOURNAL OF CLINICAL MICROBIOLOGY, 2025,
  • [24] In vitro activity of linezolid against clinical isolates of Fusobacterium spp.
    Daeschlein, G.
    Hoehne, C.
    Assadian, O.
    Daxboeck, F.
    Meinl, C.
    Kramer, A.
    Kekule, A. S.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 58 (04) : 789 - 793
  • [25] Prognostic factors in 264 adults with invasive Scedosporium spp. and Lomentospora prolificans infection reported in the literature and FungiScope® (vol 45, pg 1, 2019)
    Seidel, Danila
    Meissner, Arne
    Lackner, Michaela
    Piepenbrock, Ellen
    Salmanton-Garcia, Jon
    Stecher, Melanie
    Mellinghoff, Sibylle
    Hamprecht, Axel
    Graeff, Luisa Duran
    Kohler, Philipp
    Cheng, Matthew P.
    Denis, Julie
    Chedotal, Isabelle
    Chander, Jagdish
    Pakstis, Diana Lynn
    Los-Arcos, Ibai
    Slavin, Monica
    Montagna, Maria Teresa
    Caggiano, Giuseppina
    Mares, Mihai
    Trauth, Janina
    Aurbach, Ute
    Vehreschild, Maria J. G. T.
    Vehreschild, Jorg Janne
    Duarte, Rafael F.
    Herbrecht, Raoul
    Wisplinghoff, Hilmar
    Cornely, Oliver A.
    CRITICAL REVIEWS IN MICROBIOLOGY, 2019, 45 (02) : 238 - 238
  • [26] Comparative in-vitro activity of voriconazole (UK-109,496) and six other antifungal agents against clinical isolates of Scedosporium prolificans and Scedosporium apiospermum
    Cuenca-Estrella, M
    Ruiz-Díez, B
    Martínez-Suárez, JV
    Monzón, A
    Rodríguez-Tudela, JL
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 43 (01) : 149 - 151
  • [27] Weak Cytotoxic Activity of Miltefosine Against Clinical Isolates of Acanthamoeba spp.
    Mrva, M.
    Garajova, M.
    Lukac, M.
    Ondriska, F.
    JOURNAL OF PARASITOLOGY, 2011, 97 (03) : 538 - 540
  • [28] Antifungal activity of sertaconazole in vitro against clinical isolates of Candida spp.
    MartinMazuelos, E
    Aller, AI
    Morilla, D
    Montero, O
    CHEMOTHERAPY, 1996, 42 (02) : 112 - 117
  • [29] Potency of Olorofim (F901318) Compared to Contemporary Antifungal Agents against Clinical Aspergillus fumigatus Isolates and Review of Azole Resistance Phenotype and Genotype Epidemiology in China
    Su, Huilin
    Zhu, Min
    Tsui, Clement Kin-Ming
    van der Lee, Henrich
    Tehupeiory-Kooreman, Marlou
    Zoll, Jan
    Engel, Tobias
    Li, Li
    Zhu, Junhao
    Lu, Zihan
    Zhang, Qiangqiang
    Verweij, Paul E.
    Deng, Shuwen
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (05)
  • [30] The activity of micafungin against clinical isolates of non-albicans Candida spp.
    Biernasiuk, Anna
    Dobiecka, Ewelina
    Zdzienicka, Grazyna
    Malm, Anna
    CURRENT ISSUES IN PHARMACY AND MEDICAL SCIENCES, 2015, 28 (01) : 13 - 16
12345